ITGB1 and neoplasm: Additionally, TENASCIN was frequently observed in the HAS group, with tumor cells in this group interacting with other cells, including tumor cells themselves, via TNC - SDC1/SDC4 or TNC - ITGA8_ITGB1/ITGAV_ITGB6 (Supplementary Figure S6; Figure 4K).